Global In-Silico Drug Discovery Competitive Landscape Professional Research Report 2025

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	170 Pages	DIResearch	January, 2025	DIR19558489

Best Price Guarantee
Price	from $3,500
Length	170 Pages
Publisher	DIResearch
Published Date	January, 2025
SKU	DIR19558489

Research Summary

In-silico drug discovery, also known as computer-aided drug design, is a computational approach used to identify and optimize potential drug candidates before they are synthesized and tested in the laboratory. This methodology involves the use of computer algorithms, molecular modeling techniques, and bioinformatics tools to simulate and analyze the interactions between drug molecules and biological targets such as proteins, enzymes, or receptors. By leveraging large databases of chemical compounds, protein structures, and biological data, in-silico drug discovery enables researchers to predict the binding affinity, pharmacokinetic properties, and potential efficacy of candidate compounds in silico, thereby accelerating the drug discovery process and reducing the time and cost associated with traditional experimental approaches. In-silico methods play a crucial role in prioritizing promising drug candidates, optimizing lead compounds, and rationalizing drug design decisions, ultimately leading to the development of safer, more effective, and targeted therapeutics for various diseases.

According to DIResearch's in-depth investigation and research, the global In-Silico Drug Discovery market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global manufacturers of In-Silico Drug Discovery include Charles River, Certara USA, Inc., Evotec, Dassault System (Biovia), Albany Molecular Research Inc. (AMRI), Selvita, Schrödinger, Inc., GVK BIO, OpenEye Scientific Software, Chemical Computing Group (CCG) etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of In-Silico Drug Discovery. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global In-Silico Drug Discovery market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the In-Silico Drug Discovery market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of In-Silico Drug Discovery industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of In-Silico Drug Discovery Include:

Charles River

Certara USA, Inc.

Evotec

Dassault System (Biovia)

Albany Molecular Research Inc. (AMRI)

Selvita

Schrödinger, Inc.

GVK BIO

OpenEye Scientific Software

Chemical Computing Group (CCG)

In-Silico Drug Discovery Product Segment Include:

Software as a Service

Consultancy as a Service

In-Silico Drug Discovery Product Application Include:

Contract Research Organization

Pharmaceutical Industry

Academic and Research Institutes

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global In-Silico Drug Discovery Industry PESTEL Analysis

Chapter 3: Global In-Silico Drug Discovery Industry Porter’s Five Forces Analysis

Chapter 4: Global In-Silico Drug Discovery Major Regional Market Size and Forecast Analysis

Chapter 5: Global In-Silico Drug Discovery Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Passenger In-Silico Drug Discovery Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe In-Silico Drug Discovery Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China In-Silico Drug Discovery Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) In-Silico Drug Discovery Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America In-Silico Drug Discovery Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa In-Silico Drug Discovery Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global In-Silico Drug Discovery Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

1 In-Silico Drug Discovery Market Overview: 1.1 Product Definition and Statistical Scope; 1.2 In-Silico Drug Discovery Product by Type; 1.2.1 Software as a Service; 1.2.2 Consultancy as a Service; 1.3 In-Silico Drug Discovery Product by Application; 1.3.1 Contract Research Organization; 1.3.2 Pharmaceutical Industry; 1.3.3 Academic and Research Institutes; 1.3.4 Others; 1.4 Global In-Silico Drug Discovery Market Size Analysis (2020-2032); 1.5 In-Silico Drug Discovery Market Development Status and Trends; 1.5.1 In-Silico Drug Discovery Industry Development Status Analysis; 1.5.2 In-Silico Drug Discovery Industry Development Trends Analysis
2 In-Silico Drug Discovery Market PESTEL Analysis: 2.1 Political Factors Analysis; 2.2 Economic Factors Analysis; 2.3 Social Factors Analysis; 2.4 Technological Factors Analysis; 2.5 Environmental Factors Analysis; 2.6 Legal Factors Analysis
3 In-Silico Drug Discovery Market Porter's Five Forces Analysis: 3.1 Competitive Rivalry; 3.2 Threat of New Entrants; 3.3 Bargaining Power of Suppliers; 3.4 Bargaining Power of Buyers; 3.5 Threat of Substitutes
4 Global In-Silico Drug Discovery Market Analysis by Regions: 4.1 Global In-Silico Drug Discovery Overall Market: 2024 VS 2025 VS 2032; 4.2 Global In-Silico Drug Discovery Revenue and Forecast Analysis (2020-2032); 4.2.1 Global In-Silico Drug Discovery Revenue and Market Share by Region (2020-2025); 4.2.2 Global In-Silico Drug Discovery Revenue Forecast by Region (2026-2032)
5 Global In-Silico Drug Discovery Market Size by Type and Application: 5.1 Global In-Silico Drug Discovery Market Size by Type (2020-2032); 5.2 Global In-Silico Drug Discovery Market Size by Application (2020-2032)
6 North America: 6.1 North America In-Silico Drug Discovery Market Size and Growth Rate Analysis (2020-2032); 6.2 North America Key Manufacturers Analysis; 6.3 North America In-Silico Drug Discovery Market Size by Type; 6.4 North America In-Silico Drug Discovery Market Size by Application; 6.5 North America In-Silico Drug Discovery Market Size by Country; 6.5.1 US; 6.5.2 Canada
7 Europe: 7.1 Europe In-Silico Drug Discovery Market Size and Growth Rate Analysis (2020-2032); 7.2 Europe Key Manufacturers Analysis; 7.3 Europe In-Silico Drug Discovery Market Size by Type; 7.4 Europe In-Silico Drug Discovery Market Size by Application; 7.5 Europe In-Silico Drug Discovery Market Size by Country; 7.5.1 Germany; 7.5.2 France; 7.5.3 United Kingdom; 7.5.4 Italy; 7.5.5 Spain; 7.5.6 Benelux
8 China: 8.1 China In-Silico Drug Discovery Market Size and Growth Rate Analysis (2020-2032); 8.2 China Key Manufacturers Analysis; 8.3 China In-Silico Drug Discovery Market Size by Type; 8.4 China In-Silico Drug Discovery Market Size by Application
9 APAC (excl. China): 9.1 APAC (excl. China) In-Silico Drug Discovery Market Size and Growth Rate Analysis (2020-2032); 9.2 APAC (excl. China) Key Manufacturers Analysis; 9.3 APAC (excl. China) In-Silico Drug Discovery Market Size by Type; 9.4 APAC (excl. China) In-Silico Drug Discovery Market Size by Application; 9.5 APAC (excl. China) In-Silico Drug Discovery Market Size by Country; 9.5.1 Japan; 9.5.2 South Korea; 9.5.3 India; 9.5.4 Australia; 9.5.5 Southeast Asia
10 Latin America: 10.1 Latin America In-Silico Drug Discovery Market Size and Growth Rate Analysis (2020-2032); 10.2 Latin America Key Manufacturers Analysis; 10.3 Latin America In-Silico Drug Discovery Market Size by Type; 10.4 Latin America In-Silico Drug Discovery Market Size by Application; 10.5 Latin America In-Silico Drug Discovery Market Size by Country; 10.5.1 Mexico; 10.5.2 Brazil
11 Middle East & Africa: 11.1 Middle East & Africa In-Silico Drug Discovery Market Size and Growth Rate Analysis (2020-2032); 11.2 Middle East & Africa Key Manufacturers Analysis; 11.3 Middle East & Africa In-Silico Drug Discovery Market Size by Type; 11.4 Middle East & Africa In-Silico Drug Discovery Market Size by Application; 11.5 Middle East & Africa In-Silico Drug Discovery Market Size by Country; 11.5.1 Saudi Arabia; 11.5.2 South Africa
12 Competition by Manufacturers: 12.1 Global In-Silico Drug Discovery Market Revenue by Key Manufacturers (2021-2025); 12.2 In-Silico Drug Discovery Competitive Landscape Analysis and Market Dynamic; 12.2.1 In-Silico Drug Discovery Competitive Landscape Analysis; 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales; 12.2.3 Market Dynamic
13 Key Companies Analysis: 13.1 Charles River; 13.1.1 Charles River Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.1.2 Charles River In-Silico Drug Discovery Product Portfolio; 13.1.3 Charles River In-Silico Drug Discovery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025); 13.2 Certara USA, Inc.; 13.2.1 Certara USA, Inc. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.2.2 Certara USA, Inc. In-Silico Drug Discovery Product Portfolio; 13.2.3 Certara USA, Inc. In-Silico Drug Discovery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025); 13.3 Evotec; 13.3.1 Evotec Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.3.2 Evotec In-Silico Drug Discovery Product Portfolio; 13.3.3 Evotec In-Silico Drug Discovery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025); 13.4 Dassault System (Biovia); 13.4.1 Dassault System (Biovia) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.4.2 Dassault System (Biovia) In-Silico Drug Discovery Product Portfolio; 13.4.3 Dassault System (Biovia) In-Silico Drug Discovery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025); 13.5 Albany Molecular Research Inc. (AMRI); 13.5.1 Albany Molecular Research Inc. (AMRI) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.5.2 Albany Molecular Research Inc. (AMRI) In-Silico Drug Discovery Product Portfolio; 13.5.3 Albany Molecular Research Inc. (AMRI) In-Silico Drug Discovery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025); 13.6 Selvita; 13.6.1 Selvita Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.6.2 Selvita In-Silico Drug Discovery Product Portfolio; 13.6.3 Selvita In-Silico Drug Discovery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025); 13.7 Schrödinger, Inc.; 13.7.1 Schrödinger, Inc. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.7.2 Schrödinger, Inc. In-Silico Drug Discovery Product Portfolio; 13.7.3 Schrödinger, Inc. In-Silico Drug Discovery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025); 13.8 GVK BIO; 13.8.1 GVK BIO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.8.2 GVK BIO In-Silico Drug Discovery Product Portfolio; 13.8.3 GVK BIO In-Silico Drug Discovery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025); 13.9 OpenEye Scientific Software; 13.9.1 OpenEye Scientific Software Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.9.2 OpenEye Scientific Software In-Silico Drug Discovery Product Portfolio; 13.9.3 OpenEye Scientific Software In-Silico Drug Discovery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025); 13.10 Chemical Computing Group (CCG); 13.10.1 Chemical Computing Group (CCG) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.10.2 Chemical Computing Group (CCG) In-Silico Drug Discovery Product Portfolio; 13.10.3 Chemical Computing Group (CCG) In-Silico Drug Discovery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
14 Industry Chain Analysis: 14.1 In-Silico Drug Discovery Industry Chain Analysis; 14.2 In-Silico Drug Discovery Industry Raw Material and Suppliers Analysis; 14.2.1 In-Silico Drug Discovery Key Raw Material Supply Analysis; 14.2.2 Raw Material Suppliers and Contact Information; 14.3 In-Silico Drug Discovery Typical Downstream Customers; 14.4 In-Silico Drug Discovery Sales Channel Analysis
15 Research Findings and Conclusion
16 Methodology and Data Source: 16.1 Methodology/Research Approach; 16.2 Research Scope; 16.3 Benchmarks and Assumptions; 16.4 Date Source; 16.4.1 Primary Sources; 16.4.2 Secondary Sources; 16.5 Data Cross Validation; 16.6 Disclaimer